Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age
PHASE3
Primary Objective:
To demonstrate the non-inferiority of the antibody resp...
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
PHASE3
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico
PHASE3
Primary Objective:
1. To describe the vaccine seroprotection (antibody tit...
Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa
PHASE3
This open label randomized study will be conducted to evaluate and/or descr...